Publications by authors named "B N Azuogu"
[This corrects the article DOI: 10.1371/journal.pone.
View Article and Find Full Text PDFArticle Synopsis
- Lassa fever, recognized by the WHO as a potential pandemic threat, is a disease with significant health-economic impacts, particularly in West Africa, where it causes millions of infections and disability-adjusted life years (DALYs) each year.
- A study models vaccination strategies and estimates that a preventive campaign targeting endemic regions could save over $20 million in lost DALY value and around $128 million in societal costs over 10 years.
- In the scenario of a new variant, 'Lassa-X', emerging, effective 100 Days Mission vaccination could significantly reduce the potential health burden, illustrating the importance of vaccination in managing Lassa fever and preparing for future pandemics.
Background: Healthcare workers globally are at an increased risk of workplace violence. Adverse effects such as physical injury, reduced quality of care to patients and lower productivity with associated costs to employers occur. Non-reporting hinders the implementation of effective prevention.
View Article and Find Full Text PDFLassa fever is a zoonotic disease identified by the World Health Organization (WHO) as having pandemic potential. This study estimates the health-economic burden of Lassa fever throughout West Africa and projects impacts of a series of vaccination campaigns. We also model the emergence of "Lassa-X" - a hypothetical pandemic Lassa virus variant - and project impacts of achieving 100 Days Mission vaccination targets.
View Article and Find Full Text PDFObjective: To assess the adherence, adverse drug reactions (ADR), and virologic outcomes of dolutegravir-based antiretroviral therapy.
Design: This was a retrospective chart review.
Setting: A tertiary health facility-based study in Abakaliki, Nigeria.